B Good

Bristol-Myers Squibb Company Ce
Share · US1101221406 · CELG-RI (XNYS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Bristol-Myers Squibb Company Ce
No Price
29.04.2026 13:46
Current Prices from Bristol-Myers Squibb Company Ce
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
NYSE |
CELG-RI
|
USD
|
29.04.2026 13:46
|
0,08 USD
| 0,00 USD |
ESG Risk Rating
Share Float & Liquidity
Free Float 99,74 %
Shares Float 2,04 B
Shares Outstanding 2,04 B
Company Profile for Bristol-Myers Squibb Company Ce Share
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Company Data
Name Bristol-Myers Squibb Company Ce
Company Bristol-Myers Squibb Company Ce
Symbol CELG-RI
Website
http://www.bms.com
Primary Exchange
NYSE
NYSE
ISIN US1101221406
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Christopher S. Boerner
Market Capitalization 171 Mio
Country United States of America
Currency USD
Employees 34,1 T
Address , Princeton
Dividends from 'Bristol-Myers Squibb Company Ce'
| Ex-Date | Dividend per Share |
|---|---|
| 07.03.2024 | 0,02 USD |
| 03.03.2022 | 0,10 USD |
| 04.03.2021 | 0,14 USD |
| 18.03.2020 | 0,15 USD |
Ticker Symbols
| Name | Symbol |
|---|---|
| NYSE | CELG-RI |
More Shares
Investors who hold Bristol-Myers Squibb Company Ce also have the following shares in their portfolio:

